A recent study on soft tissue sarcoma also reported the overexpression of survivin-deltaEx3 gene to correlate with an advanced clinical stage and a poor prognosis (Taubert et al, 2005). This evidence concerns the gene BIRC5 and soft tissue sarcoma.